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Abstract
The diagnosis of solid benign and malignant tumors
presents a unique challenge to all noninvasive imaging
modalities. Ultrasound is used in conjunction with
mammography to differentiate simple cysts from solid
lesions. However, the overlapping appearances of
benign and malignant lesions make ultrasound less
useful in differentiating solid lesions, resulting in a
large number of benign biopsies. Optical tomography
using near-infrared diffused light has great potential for
imaging functional parameters of 1) tumor hemoglobin
concentration, 2) oxygen saturation, and 3) metabo-
lism, as well as other tumor distinguishing character-
istics. These parameters can differentiate benign from
malignant lesions. However, optical tomography, when
used alone, suffers from low spatial resolution and
target localization uncertainty due to intensive light
scattering. Our aim is to combine diffused light imaging
with ultrasound in a novel way for the detection and
diagnosis of solid lesions. Initial findings of two early-
stage invasive carcinomas, one combined fibroadeno-
ma and fibrocystic changewith scattered foci of lobular
neoplasia/lobular carcinoma in situ, and 16 benign
lesions are reported in this paper. The invasive cancer
cases reveal about two-fold greater total hemoglobin
concentration (mean 119 Mmol) than benign cases
(mean 67 Mmol), and suggest that the discrimination
of benign and malignant breast lesions might be
enhanced by this type of achievable optical quantifica-
tion with ultrasound localization. Furthermore, the
small invasive cancers are well localized and have
wavelength-dependent appearance in optical absorp-
tion maps, whereas the benign lesions appear diffused
and relatively wavelength-independent.
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Introduction
Ultrasound imaging is a well-developed medical diagnostic
tool that is used in conjunction with mammography for the
differentiation of simple cysts from solid lesions in breast
examinations [1]. When the criteria for a simple cyst are strictly
adhered to, the accuracy of ultrasound is 96% to 100% [2].
Ultrasound specificity in breast cancer detection, however, is
not high as a result of the overlapping characteristics of solid
benign and malignant lesions [3,4]. The insufficient predictive
value of ultrasound has prompted radiologists to recommend
biopsies on most solid nodules, which result in a large number
of biopsies yielding benign breast lesions. Currently, 70% to
80% percent of such biopsies yield benign findings [5]. In
addition, the diagnostic accuracy of ultrasound depends largely
on the experience of physicians.
Diffuse optical tomography in the near-infrared (NIR) is an
emerging modality with potential applications in radiology and
oncology [6–13]. Optical tomography with NIR light is made
possible in a spectrum window that exists within tissues in the
700- to 900-nm NIR region, in which photon transport is
dominated by scattering rather than absorption. Optical tomog-
raphy offers several functional parameters to differentiate
malignant cancers from benign lesions. It has been shown that
breast cancers have higher blood volumes than nonmalignant
tissues because of angiogenesis [14]. Tumor blood volume and
microvascular density are parameters anatomically and func-
tionally associated with tumor angiogenesis. If a single optical
wavelength is used, optical absorption related to tumor angio-
genesis and other normal blood vessels can be measured. If
two or more optical wavelengths are used, both oxyhemoglobin
(oxyHb) and deoxyhemoglobin (deoxyHb) concentrations can
be measured simultaneously. However, optical tomography
alone has not been widely used in clinical studies. The funda-
mental problem of intense light scattering remains, which
makes the target localization difficult, especially for small
lesions. In general, localization or imaging based on tomo-
graphic inverse scattering approaches suffers from low spatial
resolution and location uncertainty, and the inversion problem
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is, in general, underdetermined and ill posed. The image
reconstruction results depend on many parameters, such as
the system signal-to-noise ratio, regularization schemes
used in inversion, and so on.
Due to the above described deficiencies, literature data
on optical tomography have been limited to feasibility studies
or case reports [7–13]. However, these deficiencies can be
overcome by a novel technique using a combination of NIR
diffusive light and ultrasound [15–18]. The combined imager
consists of a hand-held probe housing a commercial ultra-
sound probe and NIR source and detectors for coregistra-
tion. Ultrasound is used to scan suspicious lesions, whereas
coregistered optical measurements are used to image and
characterize the functional parameters of the lesions. With
the a priori knowledge of lesion structure initially obtained by
ultrasound, the tissue volume can be approximately seg-
mented into a lesion region and a background region; optical
reconstruction from the optical measurements can be per-
formed by using finer imaging voxel size corresponding to
the lesion region and coarse voxel size corresponding to the
background region [18]. Consequently, the image recon-
struction is well defined because the total number of imaging
voxels with unknown optical properties is reduced signifi-
cantly. In addition, the reconstruction is less sensitive to
noise because the weight matrix is appropriately scaled for
inversion, and convergence can be achieved within a small
number of iterations.
In this paper, we report our initial clinical results of using
the combined technique to image and characterize ultrason-
ically detected breast lesions. A total of 18 patients (19
cases) of invasive breast carcinomas (2 cases), combined
fibroadenoma and fibrocystic changes with scattered foci of
lobular neoplasia/lobular carcinoma in situ (noninvasive car-
cinoma; 1 case), juvenile atypical ductal hyperplasia (1
case), and fibroadenomas and fibrocystic changes (15
cases) are reported here. The diameters of these lesions
are on the order of 1 cm. For the first time, we report high
sensitivity of optical tomography in diagnosing early-stage
invasive cancers and in differentiating them from small
benign lesions. We also show a highly localized pattern of
angiogenesis distribution of small invasive cancers. Our
initial results are very encouraging and suggest that the
discrimination of benign and malignant breast masses could
be enhanced by this type of achievable optical quantification
coupled with ultrasound localization.
Materials and Methods
The major technical aspects of our combined imaging tech-
nique have been described in detail previously [16]. Briefly,
the NIR system consists of 12 pairs of dual-wavelength (780
and 830 nm) laser diodes, which are used as light sources,
and their outputs are amplitude-modulated at 140 MHz. For
each source pair, the outputs from the two laser diodes at
both wavelengths were coupled to the tissues through a 200-
mm optical fiber. On the receiver side, eight photomultiplier
tubes (PMTs) were used to detect diffusely scattered light
from the tissues, and eight optical fibers (3 mm in diameter)
were used to couple detected diffusive light from the tissues
to the PMTs. The high-frequency radiofrequency (RF) sig-
nals were amplified and heterodyned to 20 kHz. The hetero-
dyned signals were further amplified and band pass–filtered
at 20 kHz. A reference signal of 20 kHz was also generated
by directly mixing the detected RF signals with the RF signal
generated from the oscillator. The reference signal was
necessary for retrieving phase shifts. Eight detection signals
and one reference were sampled and acquired into the PC
simultaneously. The entire data acquisition took about 3 to 4
seconds, which was fast enough for acquiring data from
patients.
A picture of our combined probe and imaging system
used in the reported clinical studies is shown in Figure 1a,
and the probe configuration and optical sensor distribution
are shown in Figure 1b. Both amplitude and phase at each
source–detector pair are obtained and the resulting total
number of measurements is 12  8  2 = 192. The com-
bined probe is made of a black plastic plate 10 cm in
diameter; therefore, a semi-infinite boundary condition can
be used for NIR measurement geometry. The amplitudes
and phases acquired at all source–detector pairs at the
normal contralateral breast were used to calculate the
Figure 1. (a) Picture of the combined probe and frequency domain imager.
(b) Sensor distribution of the combined probe. Smaller circles in (b) are
optical source fibers and big circles are detector fibers. A commercial
ultrasound probe is located at the center of the combined probe, and the
optical source and detector fibers are distributed at the periphery of the
ultrasound probe.
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background absorption coefficient l¯a and the reduced
scattering coefficient l¯sV.
The details of our dual-mesh optical imaging reconstruc-
tion algorithm have been described in Ref. [18]. Briefly, the
entire tissue volume is segmented based on initial coregis-
tered ultrasound measurements into a lesion region L and a
background region B. A modified Born approximation is used
to relate the scattered field Usd(rsu,rdt,x) measured at the
source (s) and detector (d) pair i to absorption variations Dma
(r V) in each volume element of two regions within the sample.
The matrix form of image reconstruction is given by:
½UsdMl ¼ ½WL;WBMN ½ML;MBTN1
where WL and WB are weight matrices for lesion and back-
ground regions, respectively; and ½ML ¼ ½
R
1L
Dlaðr VÞd3r V; . . .
. . .
R
NL
Dlaðr VÞd3r V and ½MB ¼ ½
R
1B
Dlaðr VÞd3r V; . . . . . .
R
NB
Dlaðr VÞd3r VÞ are total absorption distributions of lesion and
background regions, respectively. The weight matrices are
calculated based on the background l¯a and l¯sV measure-
ments obtained from the normal contralateral breast.
Instead of reconstructing the Dla distribution directly, as
is done in the standard Born approximation, the total absorp-
tion distributionM is reconstructed and the total is divided by
different voxel sizes of lesions and background tissues to
obtain the Dla distribution. By choosing a finer grid for lesion
and a coarse grid for background tissues, we can maintain
the total number of voxels with unknown absorption on the
same scale of the total measurements. As a result, the
inverse problem is less underdetermined. In addition, be-
cause the lesion absorption coefficient is higher than that of
background tissues, in general, the total absorption of the
lesion over a smaller voxel is on the same scale as the total
absorption of the background over a bigger voxel. Therefore,
the matrix [ML,MB] is appropriately scaled for inversion. In all
experiments, a finer grid of 0.5  0.5  0.5 (cm3) and a
coarse grid of 1.5  1.5  1.5 (cm3) were chosen for the
lesion region and the background tissues, respectively. The
total reconstruction volume was chosen to be 9  9  4
cm3. The reconstruction is formulated as a least square
problem and the unknown distribution M is iteratively calcu-
lated using the standard conjugate gradient method.
The perturbations for both wavelengths used to calculate
absorption maps were normalized as Usdðrsi; rdi;xÞ ¼
ULðrsi ;rdi ;xÞUNðrsi;rdi ;xÞ
UNðrsi ;rdi;xÞ UBðrsi; rdi;xÞ; where ULðrsi; rdi;xÞ and UN
ðrsi; rdi;xÞ were optical measurements obtained at the lesion
region and the normal region of the contralateral breast, and
UB(rsi,rdi,x) was the calculated incident field using the
measured background. This procedure cancels the un-
known system gains associated with different sources and
detectors as well as electronic channels.
The commercial one-dimensional (1-D) ultrasound probe
acquires two-dimensional (2-D) ultrasound images in the x–
z plane (z is the propagation direction) and the 2-D NIR probe
provides three-dimensional (3-D) optical measurements for
3-D image reconstruction. Therefore, at each location, a 2-D
ultrasound image is coregistered with a corresponding set of
3-D optical measurements in the x–z plane. However, if we
approximate a lesion as an ellipsoid, we are able to estimate
its diameters from two orthogonal ultrasound images. The
3-D lesion center can be approximated from two orthogonal
2-D ultrasound images. However, two sources of error can
affect accurate lesion location and volume estimation. First,
the diameter measurements of large irregular lesions are
inaccurate because lesion boundaries may not be well
defined in ultrasound images. Second, the target boundaries
seen by different modalities may be different due to different
contrast mechanisms. To account for these errors, we use a
lesion center estimated from the 2-D coregistered ultrasound
image and use much larger diameters in both spatial dimen-
sions than ultrasound-measured ones to highlight the lesion
region for fine-mesh optical reconstruction. We have found
from experiments that the abovementioned measurement
inaccuracies have little effects on reconstructed optical prop-
erties as long as the lesion depth is measured correctly and
the total number of unknown voxels is of the same order
as the total number of measurements. The lesion depth z
and the lesion boundaries in the z direction can be estimated
reasonably well from 2-D coregistered ultrasound using
normal tissue structure patterns.
Clinical studies were performed at the University of
Connecticut Health Center (UCHC; Farmington, CT). The
UCHC IRB committee approved the human subject proto-
col. Patients with palpable and nonpalpable masses that
were visible on clinical ultrasound and who were scheduled
for biopsy were enrolled as research subjects. These
subjects were scanned with the combined probe, and
ultrasound images and optical measurements were ac-
quired at multiple locations including the lesion region
scanned at two orthogonal positions, a normal region of
the same breast if the breast was large, and a normal
symmetric region of the contralateral breast also scanned
at two orthogonal positions.
Results
Examples of Invasive Cancers
Figure 2a shows a gray scale ultrasound image of a
nonpalpable lesion of a 55-year-old woman. The ultrasound
showed a nodular mass with internal echoes and the lesion
was considered suspicious. The estimated lesion diameter
measured from two orthogonal ultrasound images was 8mm.
An ultrasound-guided core needle biopsy was recommended
and the biopsy result revealed that the lesion was intraductal
and infiltrating ductal carcinoma (nuclear grade II, histologic
grade III). The cancer, once removed from the breast,
measured 1 cm in greatest diameter, and was composed
predominantly of invasive carcinoma (>95%), extending to
surgical margins. Negative margins were achieved upon
reexcision.
The average tissue background absorption coefficients m¯a
and the reduced scattering coefficients l¯sV at 780 and
830 nm were measured as la
780 = 0.02 cm1, lsV780 =
8.2 cm1, la
830 = 0.04 cm1, and lsV830 = 6.0 cm1, respec-
tively. The initial estimates of the lesion center and the
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diameter from coregistered ultrasound were (0, 0.3, 2.3) cm
and 8 mm. To account for errors in lesion geometry estimate
and for differences in optical contrast, we used a 6-cm
diameter in both x and y spatial dimensions at the center of
(0, 0.3, 2.3) cm for fine-mesh optical reconstruction. The
lesion diameter in depth is estimated as 1 cm by comparing
the top and the bottom of lesion boundaries from normal
tissue patterns. The white arrow arrays on the top and bottom
of the lesion in Figure 2a point to normal tissue boundaries.
The optical absorption maps at both wavelengths are
shown in Figure 2, b and c, respectively. In both Figure 2,
b and c, the first slice is 0.7 cm deep into the breast tissue
from the skin surface and the last slice is closer to the chest
wall. The spacing of the slices is 0.5 cm. The horizontal and
vertical axes of each slice are spatial x and y dimensions of 9
cm in size. The lesion is well resolved in slice 5 and has
shown much larger spatial extension at 830 nm than that at
780 nm. The measured maximum absorption coefficients are
la
780 = 0.24 cm1 and la
830 = 0.28 cm1, respectively, and the
absorption maxima at both wavelengths are located at (0,
1.0, 2.3) cm, which is close to the lesion center measured by
ultrasound.
By assuming that the major chromophores are oxygen-
ated (oxyHb) and deoxygenated (deoxyHb) hemoglobin
molecules in the wavelength range studied, we can esti-
mate the distribution of total hemoglobin concentration as
shown in Figure 2d. The extinction coefficients used for cal-
culating oxyHb and deoxyHb concentrations were eHb
780 =
2.54, eHbO2
780 = 1.70, eHb
830 = 1.80, eHbO2
830 = 2.42, obtained
from Ref. [19] in a natural logarithm scale with units of
inverse millimoles times inverse centimeters. The measured
maximum total hemoglobin concentration for lesions is
122 mmol, and the measured average background hemo-
globin concentration is 14 mmol. The spatial extent of the
lesion’s angiogenesis is measured from the full width at half
maximum (FWHM) of the total hemoglobin map and it is
estimated to be 2.0 cm. This number is about two and half
times larger than the 8 mm diameter measured by ultra-
sound and suggests that optical contrasts extend well
beyond the cancer periphery due to angiogenesis.
Because our hand-held probe can be easily rotated or
translated, we have acquired at least three coregistered
ultrasound and NIR data sets at the lesion location for
each patient and have reconstructed corresponding optical
absorption maps as well as the total hemoglobin concen-
tration distribution under the coregistered ultrasound guid-
ance. The average maximum total hemoglobin
concentration at the cancer region is 115 mmol (±27.6
mmol) and the average background total hemoglobin con-
centration is 13 mmol (±1.5 mmol). The large standard
deviation at the cancer region is likely related to the probe
compression at different spatial locations and elastic prop-
erties of the blood vessels in the cancer region.
Another example was obtained from a 56-year-old
woman who had a solid mass with internal ultrasound
echoes measuring 9 mm in size (Figure 3a). The lesion
was considered suspicious, and ultrasound-guided core
needle biopsy revealed that the lesion was in situ and
invasive ductal carcinoma (nuclear grade II, histologic
grade II). The tumor, once removed from the breast,
measured 1.5 cm in greatest diameter, and was composed
predominantly of invasive carcinoma (>80%), extending to
the inferior/anterior surgical margin. Negative inferior mar-
gin was achieved upon reexcision.
The average tissue background absorption coefficient m¯a
and the reduced scattering coefficient m¯Vs at 780 and 830 nm
were measured as la
780 = 0.04 cm1, lsV830 = 4.7 cm1, la780
= 0.03 cm1, and laV830 = 5.8 cm1, respectively. The initial
estimate of the lesion center and diameters from coregis-
tered ultrasound were (0, 0.6, 1.9) cm and 9 mm, respec-
tively. Again, we used a 6-cm diameter in both x and y spatial
dimensions at the center of (0, 0.6, 1.9) for fine-mesh optical
reconstruction. The optical absorption maps at both wave-
lengths are shown in Figure 3, b and c, respectively. In
Figure 3, b and c, the first slice is 0.4 cm deep into the breast
tissues from the skin surface and the last slice is closer to the
chest wall. The spacing between the slices is 0.5 cm. This
lesion is well resolved in slice #4 and has shown much larger
spatial extension at 780 nm than that at 830 nm. The
measured maximum absorption coefficients are la
780 = 0 .29
cm1 and la
830 = 0.25 cm1, respectively. The absorption
maxima at both wavelengths are located at (0,1.0,1.9000)
cm, which is very close to the lesion center measured by
ultrasound. The calculated maximum total hemoglobin con-
centration of the lesion is 128 mmol, and the background
concentration is 24 mmol. The measured FWHM of the total
hemoglobin map is 3.5 cm, which is more than three times
larger than the 9 mm diameter measured by ultrasound and
again suggests that optical contrasts extend well beyond the
cancer periphery due to angiogenesis. The average maxi-
mum total hemoglobin concentration calculated from three
NIR data sets is 123 mmol (±6.2 mmol) and the average back-
ground hemoglobin concentration is 24 mmol (±0.5 mmol).
The variation of total hemoglobin concentrations acquired at
slightly different spatial probe positions is much smaller than
that in the previous case.
An Example of Combined Fibroadenoma and Fibrocystic
Changes with Scattered Foci of Lobular Neoplasia/Lobular
Carcinoma In Situ (Noninvasive Carcinoma)
This patient had a solid lesion measuring 1.1 cm in
diameter as shown in Figure 4a ultrasound image. The lesion
was diagnosed as having a benign appearance; however,
the biopsy result revealed combined fibrocystic changes
associated with microcalcifications and scattered foci of
lobular neoplasia/lobular carcinoma in situ with pagetoid
extension along ducts, but no invasive carcinoma. Also
present was a fibroadenoma involved by lobular neoplasia.
The average background tissue absorption coefficients
and reduced scattering coefficients at both wavelengths
were measured as la
780 = 0.04 cm1, lsV780 = 3.3 cm1,
la
830 = 0.02 cm1, and lsV830 = 3.5 cm1, respectively. The
initial estimate of the lesion center and the diameter from
ultrasound were (0, 0.9, 1.4) and 1.1 cm. The reconstructed
absorption maps as well as total hemoglobin concentration
distribution are shown in Figure 4, b–d, respectively. The
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Figure 2. (a) shows a gray scale ultrasound image of a nonpalpable lesion of a 55-year-old woman. The lesion pointed by the arrow was located at the 4 o’clock
position of the right breast measuring 8 mm in diameter. Ultrasound showed nodular mass with internal echoes and the lesion was considered suspicious. (b) and
(c) are optical absorption maps at 780 and 830 nm, respectively. x and y axes are spatial dimensions of 9  9 cm. The slices starting from left to right correspond to
absorption maps from 0.7 cm underneath the skin surface to the chest wall in 0.5-cm spacing. (d) is the total hemoglobin concentration and the vertical scale is
in micromoles.
Figure 3. This example was obtained from a 56-year-old woman who had nonpalpable lesion located at the 10 o’clock position of the left breast. Ultrasound
showed a solid mass (a) with internal echoes measuring 9 mm in size and the lesion was considered suspicious. (b) and (c) are optical absorption maps at 780 and
830 nm, respectively. The slices start from 0.4 cm underneath the skin surface to the chest wall in 0.5-cm spacing. (d) is the total hemoglobin concentration.
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Figure 4. (a) shows a solid lesion at the 2 o’clock position measuring 1.1 cm in diameter in ultrasound image. The lesion was diagnosed as having benign
appearance because of well-defined boundaries. Ultrasound-guided core biopsy revealed scattered foci of lobular neoplasia, carcinoma in situ but not invasive, and
fibroadenoma and fibrocystic changes with associated microcalcifications. (b) and (c) are optical absorption maps at 780 and 830 nm, respectively. The slices start
from 0.5 cm underneath the skin surface to the chest wall in 0.5-cm spacing. (d) is the total hemoglobin concentration.
Figure 5. (a) shows an ultrasound image of a solid hypoechogenic lesion located at 9 to 10 o’clock position of a 37-year-old woman’s breast. The diagnosis was
that the lesion could represent fibroadenoma; however, there was a chance that the lesion could be a carcinoma because of the irregular shape and posterior
shadow seen by ultrasound. (b) and (c) are optical absorption maps at 780 and 830 nm, respectively. The slices start from 0.5 cm underneath the skin surface to
the chest wall in 0.5-cm spacing. (d) is the total hemoglobin concentration.
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measured maximum absorption coefficients are la
780 = 0.13
cm1 and la
830 = 0.09 cm1, respectively, which are about
half of those measured in invasive cancer cases. In addition,
the absorption coefficient distributions are diffused at both
wavelengths and no resolvable or localized lesions are seen.
The calculated maximum total hemoglobin concentration is
53 mmol, which is less than half of those in invasive cancer
cases. The calculated background value is 13 mmol. The
average maximum hemoglobin concentration calculated
from four reconstructed NIR images at lesion location is
48 mmol (±2.8 mmol) and the value for the background is
12 mmol (±0.4 mmol). This example suggests that tumor
vascularization may not be developed at the early noninva-
sive stage of combined fibrocystic change and neoplasia/
carcinoma in situ.
Example of Fibroadenoma and Other Benign Lesions
Figure 5a shows an ultrasound image of a hypoechoic
mass of a 37-year-old woman. The diagnosis was that the
lesion likely was a fibroadenoma; however, there was
concern that the lesion could be a carcinoma because of
the irregular shape and the posterior shadowing seen by
ultrasound. An ultrasound-guided core breast biopsy
revealed that the lesion was simply a fibroadenoma.
Optical absorption maps are shown in Figure 5, b and c,
as well as the total hemoglobin distribution in Figure 5d.
Compared with the invasive cancer cases, the spatial dis-
tributions of the absorption coefficients as well as the total
hemoglobin concentration are quite diffused, and a higher
absorption region at 830 nm corresponds to lesion regions
seen by ultrasound. The measured maximum lesion ab-
sorption coefficients at 780 and 830 nm are la
780=0.10 cm1
and la
830=0.12 cm1, respectively, and these values are less
than half of those small invasive cancer cases. The calcu-
lated maximum total hemoglobin concentration is 52 mmol
and the background hemoglobin concentration is 14 mmol.
The calculated average maximum total hemoglobin concen-
tration from four NIR images acquired at lesion region is 59
mmol (±5.1 mmol) and the average background is 16 mmol
(±1.0 mmol).
Table 1 lists all the measured parameters of the 19 cases
[from left to right: biopsy result, lesion size measured by
ultrasound in x and z dimensions (because lesions are small,
the lesion size in y is similar to that measured in the x
dimension), region of interest (ROI) used for fine-mesh NIR
imaging, FWHM measured from NIR imaging, maximum
absorption coefficients measured at both wavelengths,
maximum and average total hemoglobin concentrations
(the average is computed within FWHM)]. For the two
invasive cancer cases, NIR parameters are given for two
different ROIs and the results show that the choice of ROI
has negligible effects on the absorption and hemoglobin
measurements.
The statistics of maximum total hemoglobin concentration
of three groups obtained from the 19 cases are shown in
Figure 6. The benign group of fibroadenoma (15 cases) and
hyperplasia (1 case) has an average of 67 mmol (±17.0
mmol), the combined fibroadenoma and fibrocystic change
with noninvasive neoplasia/carcinoma in situ case has a
maximum of 48 mmol, and the invasive cancer group of two
cases has shown about two-fold greater average of 119 mmol
(±1.6 mmol). If average total hemoglobin concentration is
used, the values are 46 (±11.3), 30, and 86 (±2.12) mmol for
the three corresponding groups, respectively. The malignant
group also presents about two-fold greater average hemo-
globin concentration than that of the benign group. The
average sizes of lesions of the three groups measured by
ultrasound are 1.05 (±0.3), 1.1, and 0.9 (±0.07) cm, respec-
tively. The lesion size is the geometric mean of diameters
measured in x and z dimensions.
Because our study is in its early clinical trial stage, we
do not intend to provide the sensitivity and specificity of the
combined method due to the limited sample size available.
However, our initial findings are very encouraging and
suggest that early-stage small invasive cancers have much
higher optical contrast than benign lesions and could be
diagnosed with high specificity possibly due to tumor
angiogenesis.
Discussion
As described earlier, due to intense light scattering, optical
tomography alone has not been widely used in clinical
studies. Data in the published literature have been limited
to feasibility studies or case reports. Pogue et al. [9] reported
pilot results of one invasive ductal carcinoma 1 cm in size
and one benign fibroadenoma 3 cm in size. The reported
maximum total hemoglobin concentrations were 68 mmol for
the cancer case and 55 mmol for the benign case. Although
the invasive cancer size reported by this group is comparable
to ours, the system they used can only acquire NIR data from
a ring area with optical sources and detectors deployed
around the breast (2-D imager). Therefore, incomplete infor-
mation could lead to smaller reconstructed absorption coef-
ficients and total hemoglobin concentrations than those
reported here using our 3-D NIR imager. In addition, an
investigation with phantoms has shown that NIR alone, in
general, reconstructs lower absorption coefficients and
therefore lower total hemoglobin concentrations than true
values [20]. This can be seen from two studies of the same
data reported in Refs. [7,13]. Authors in Ref. [7] reported an
average of 35 mmol total hemoglobin concentration of a 2-cm
ductal carcinoma in situ by using NIR measurements alone.
After reprocessing the same NIR measurement data using
an approximate lesion depth obtained from a separate
ultrasound image, the authors reported that the calculated
average total hemoglobin concentration was increased to 67
mmol [13].
The reported small early-stage invasive cancers appear
isolated and are well resolved from background tissues in
optical absorption maps as well as in total hemoglobin
distributions. However, the combined fibroadenoma and
fibrocystic change with scattered foci of lobular neoplasia/
lobular carcinoma in situ case showed no difference in
optical absorption and hemoglobin concentration than those
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obtained from fibroadenoma cases. This suggests that opti-
cal tomography may not be sensitive to early-stage mixed
benign changes and noninvasive neoplasia/carcinoma in situ
because tumor neovascularization has not been developed.
This result is consistent with magnetic resonance imaging
(MRI) findings on the low detection sensitivity of carcinoma in
situ [21–23]. However, optical imaging may be a valuable
tool for monitoring the development or transition of lesions
from noninvasive to early invasive stage. Certainly, more
cases are needed to validate the observations reported here.
For larger cancers, highly heterogeneous wavelength-de-
pendent optical absorption distributions and total hemoglobin
distribution have been observed in four cases [18], and these
distributions could provide valuable information for monitor-
ing and assessing cancer therapy under treatment. Current-
ly, we are pursuing research along this line and more cases
will be reported in the future.
In principle, the distribution of oxygenation saturation can
be estimated as S = oxyHb/(oxyHb+deoxyHb), with deox-
yHb and oxyHb distributions calculated from absorption
maps at the two wavelengths of 780 and 830 nm. However,
because background tissues mainly consist of water and
lipid and these two chromophores contribute to the total
absorption estimate as well, we could not obtain reasonable
background oxygenation saturation and compare it with
lesion oxygenation saturation. Recently, we have improved
our NIR system by adding another wavelength at 660 nm,
which may allow us to accurately estimate the background
oxygenation saturation and to compare it with lesion oxy-
genation saturation.
If we reconstruct the lesion area only, we could distribute
partial perturbations caused by background to lesion and
increase calculated lesion absorption and therefore hemo-
globin concentration. However, with the dual-mesh scheme,
Table 1. Measured Parameters of 19 Cases.
Reference
Number
Biopsy Results Lesion Size
(Ultrasound) [cm]
ROI FWHM
(NIR) [cm]
Max la [cm
1],
780 nm
Max la [cm
1],
830 nm
Max Total
Hb [mM]
Average
Total
Hb [mM]
13 Invasive cancer 0.9  0.6 6  6  1 3.5 0.28 0.24 123 87
10  10  1 3.5 0.27 0.24 122 88
25 Invasive cancer 0.8  0.5 6  6  1 2.0 0.22 0.26 115 84
10  10  1 2.1 0.22 0.26 115 84
32 Fibrocystic and lobular
neoplasia/carcinoma
1.1  1.1 10  10  1.2 6.1 0.12 0.08 48 30
11 Fibroadenoma 1.2  0.8 8  8  1 4.9 0.11 0.10 49 37
8 Fibroadenoma 2.2  1.3 8  8  1.6 2.7 0.07 0.03 24 16
9 Fibroadenoma 0.9  0.7 8  8  1 4.9 0.15 0.18 77 52
7 Fibroadenoma and
sclerosing adenosis
with extensive
calcification
1.0  0.6 10  10  1 3.8 0.16 0.11 59 41
17 Fibrocystic changes 0.6  0.7 10  10  1 5.8 0.16 0.16 76 53
20 Fibroadenoma 1.2  0.6 10  10  1 5.7 0.14 0.14 67 45
30 1: Fibrocystic change 1.7  1.1 8  8  1.3 4.0 0.10 0.15 59 39
30 2: Sclerosing adenosis
and epithelial
hyperplasia
without atypical
1.4  1.2 8  8  1.3 4.0 0.15 0.23 88 57
22 Fibroadenoma 1.0* 10  10  1.5 3.7 0.15 0.15 72 46
36 Fibroadenoma 1.9  0.9 9  9  1 4.7 0.13 0.18 73 50
28 Fibroadenoma 1.9  1.1 9  9  1.3 4.2 0.14 0.16 71 45
33 Fibroadenoma 1.2  0.7 10  10  1 7.0 0.13 0.13 61 44
37 Fibroadenoma 0.8  0.6 8  8  1 6.0 0.16 0.18 80 53
35 Fibroadenoma 1.3  1.3 9  9  2 4.3 0.14 0.15 59 41
38 Hyalinized fibroadenoma 0.8  0.4 6  6  1 2.5 0.17 0.22 90 67
29 Atypical ductal hyperplasia 1.1  0.8 9  9  1 3.7 0.10 0.17 64 44
*See by X-ray.
Figure 6. The average maximum total hemoglobin concentration obtained
from benign fibroadenomas and hyperplasia, and combined fibroadenoma
and fibrocystic change with neoplasia/carcinoma in situ (noninvasive) and
invasive cancer groups are shown in bars. The standard deviations of three
groups are also provided. The average sizes of lesions of the three groups
are 1.05 (0.3), 1.1, and 0.9 (0.07) cm, respectively.
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we reconstruct the entire imaging volume instead of the
lesion area only, and distribute the perturbations to both
lesion and background. We did phantom experiments using
the dual-mesh scheme and obtained absorption coefficients,
which were always within 10% of the true values depending
on the phantom contrasts [24].
Two-dimensional ultrasound provides fine tissue layer
structures in depth (z) direction (Figure 2, arrow arrays),
and the 2-D ultrasound image is coregistered with optical
data in z. Therefore, we only need to consider possible
angiogenesis extensions in z and we have extended the
lesions to the closest normal tissue lines in z. In spatial
dimensions, we have some uncertainty in another dimension
( y) based on 2-D x–z ultrasound image, and we need to
extend the lesion region to a larger area to account for this as
well as for possible angiogenesis extension.
The reported optical tomography study was used to
image and characterize ultrasonically detected lesions. How-
ever, in one benign fibroadenoma case, the lesion was not
visible in ultrasound but was seen by conventional X-ray
mammogram. By knowing the approximate lesion region
with respect to the nipple location from the patient’s mam-
mogram, we used a fine mesh for optical reconstruction in a
larger region of 9  9  1.5 cm3, and identified a possible
lesion that showed slightly higher optical absorption than that
of the background. We believe that optical tomography,
assisted by conventional mammography and/or ultrasound
localization, has potential as a screening tool to identify and
characterize malignancy.
Our initial findings provide evidence that optical tomogra-
phy, combined with ultrasound, could be used to differentiate
early-stage small invasive breast cancers from benign
lesions. Because of the limited sample size available, we
are not able to provide sensitivity and specificity results in
this paper. In addition, for the patients studied, four fibroa-
denoma cases and one intraductal hyperplasia were exclud-
ed from the statistics shown in Figure 6. The four
fibroadenoma cases were scanned at the beginning of the
study. One patient was scanned after core biopsy due to
scheduling problem, and the possible blood distribution
change due to biopsy procedure has to be considered. The
other three young patients have small and dense breasts.
For these three patients, the optical amplitude and phase
data sets were highly scattered even in the normal contra-
lateral breast. Therefore, no reliable background tissue
absorption and scattering coefficients can be obtained.
Three possible sources for these findings were identified.
First, because these breasts were small and dense, the skin
and probe contact was not always good. Second, a thick gel
layer used for coupling the ultrasound transducer with the
skin can serve as a light tunneling medium from sources to
detectors. This portion of the light can saturate the detectors
and give false readings. Caution was taken in the later
studies by compressing the probe harder against the ex-
amined breast to ensure good probe–tissue contact, and by
placing a very thin gel layer underneath the ultrasound
transducer during scanning. The third source are tissue
heterogeneities of the young dense breasts. However, by
carefully removing outliers from normal breast data, we
could obtain reasonably good reference data for imaging.
One patient with intraductal hyperplasia data was excluded
from the study. This patient had a solid lesion located at the
nipple area and the nipple had a very dark color. Four NIR
image data sets obtained at the lesion area had the same
artifacts and the artifact consistently showed up with very
high absorptions at both wavelengths. When the lesion
locations were changed in different images with different
probe positions, the artifact location changed very little. A
similar artifact showed up in the two reference data sets
acquired in the contralateral normal breast. We do not know
the exact source of this artifact because there was no report
that this patient had problems at the contralateral breast.
Care was taken in the later studies by acquiring at least four
reference data sets at the normal symmetric region of the
contralateral breast, as well as at normal regions of the
same lesion breast. Reference data sets were always
checked for normal background absorption changes before
imaging the lesions.
Summary
Initial clinical results from the use of optical tomography
combined with conventional ultrasound demonstrate that
there is a huge optical contrast between early-stage invasive
cancers and benign solid lesions due to angiogenesis. An
average of 52 mmol difference was obtained between two
small invasive cancers and a group of 16 benign solid
lesions. In addition, the small invasive cancers were local-
ized well in absorption maps and have shown wavelength-
dependent absorption changes, whereas the benign lesions
appeared more diffused in absorption maps and have shown
relatively wavelength-independent absorption changes. The
combined fibrocystic changes and noninvasive neoplasia/
carcinoma in situ case did not show a significant difference in
optical absorption and total hemoglobin concentration than
those of benign lesions. This suggests that the angiogenesis
may not be developed at the early noninvasive stage of the
mixed benign changes and fibroadenoma with neoplasia/
carcinoma in situ. However, optical tomography may have a
potential role in monitoring the development and/or transition
of cancers from the noninvasive to the invasive stage.
Our reported initial results are very encouraging and
demonstrate that our unique approach, which combines
optical tomography with ultrasound, has great potential to
detect and characterize breast lesions.
Acknowledgements
The authors thank Ellen Oliver, surgical nurse of the Cancer
Center of the UCHC, for her continuous efforts on patient
scheduling. Q. Zhu expresses her sincere thanks to Prof.
Britton Chance of the University of Pennsylvania for his
continuous encouragement and support on combined imag-
ing and valuable discussions on cancer biology. Graduate
students Puyun Guo, Shikui Yan, and Daqing Piao are
Ultrasound-Guided Imaging of Breast Lesions Zhu et al. 387
Neoplasia . Vol. 5, No. 5, 2003
acknowledged for their continuous help on the NIR system
construction and improvement.
References
[1] Stavros TA, Thickman D, and Rapp C (1995). Solid breast nodules: use
of sonography to distinguish between benign and malignant lesions.
Radiology 196, 123–34.
[2] Sickles EA (1998). Detection and diagnosis of breast cancer with mam-
mography. Perspect Radiol 1, 36–65.
[3] Rahbar G, Sie AC, Hansen GC, Prince JS, Melany ML, Reynolds H,
Jackson VP, Sayre JW, and Bassett LW (1999). Benign versus malig-
nant solid breast masses: US differentiation. Radiology 213, 889–94.
[4] Jackson VP (1995). The current role of ultrasonography in breast imag-
ing. Radiol Clin North Am 33, 1161–170.
[5] Sickles EA (1988). Detection and diagnosis of breast cancer with mam-
mography. Perspect Radiol 1, 36–65.
[6] Yodh A, and Chance B (1995). Spectroscopy and imaging with diffusing
light. Phys Today 48, 34–40.
[7] Tromberg B, Shah N, Lanning R, Cerussi A, Espinoza J, Pham T,
Svaasand L, and Butler J (2000). Non-invasive in vivo characterization
of breast tumors using photon migration spectroscopy. Neoplasia 2
(1:2), 26–40.
[8] Franceschini MA, Moesta KT, Fantini S, Gaida G, Gratton E, Jess H,
Seeber M, Schlag PM, and Kashke M (1997). Frequency-domain tech-
niques enhance optical mammography: initial clinical results. Proc Natl
Acad Sci 94, 6468–473.
[9] Pogue B, Poplack SP, McBride TO, Wells WA, Osterman K, Oster-
berg U, and Paulsen KD (2001). Quantitative hemoglobin tomography
with diffuse near-infrared spectroscopy: pilot results in the breast.
Radiology 218, 261–66.
[10] Dehghani H, Pogue B, Poplack SP, and Paulsen KD (2003). Multi-
wavelength three-dimensional near-infrared tomography of the
breast: initial simulation, phantom, and clinical results. Appl Opt 42
(1), 135–45.
[11] Ntziachristos V, Yodh A, Schnall M, and Chance B (2000). Concurrent
MRI and diffuse optical tomography of breast after indocyanine green
enhancement. Proc Natl Acad Sci 97 (6), 2267–772.
[12] Jiang H, Xu Y, Iftimia N, Eggert J, Klove K, Baron L, and Fajardo L
(2001). Three-dimensional optical tomographic imaging of breast in a
human subject. IEEE Trans Med Imaging 20 (12), 1334–340.
[13] Jholboke M, Tromberg B, Li X, Shah N, Fishkin J, Kidney D, Butler J,
Chance B, and Yodh A (2000). Three-dimensional diffuse optical mam-
mography with ultrasound localization in human subject. J Biomed Opt
5 (2), 237–47.
[14] Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and
nutrient supply, and metabolic microenvironment of human tumors: a
review. Cancer Res 49, 6449–465.
[15] Zhu Q, Durduran T, Holboke M, Ntziachristos V, and Yodh A (1999).
Imager that combines near infrared diffusive light and ultrasound. Opt
Lett 24 (15), 1050–1052.
[16] Chen NG, Guo PY, Yan SK, Piao DQ, and Zhu Q (2001). Simultaneous
near infrared diffusive light and ultrasound imaging. Appl Opt 40 (34),
6367–380.
[17] Zhu Q, Conant E, and Chance B (2000). Optical imaging as an adjunct
to sonograph in differentiating benign from malignant breast lesions.
J Biomed Opt 5 (2), 229–36.
[18] Zhu Q, Chen NG, and Kurtzman HS (2003). Imaging tumor angiogen-
esis by the use of combined near infrared diffusive light and ultrasound.
Opt Lett 28 (5), 337–39.
[19] Cope M (1991). PhD Dissertation University of College London.
[20] Zhu Q, Chen NG, Piao DQ, Guo PY, and Ding XH (2001). Design of
near infrared imaging probe with the assistance of ultrasound localiza-
tion. Appl Opt 40 (19), 3288–303.
[21] Gilles R, Zafrani B, Guinebretiere JM, Meunier M, Lucidarme O, Tardi-
von AA, Rochard F, Vanel D, Neuenschwander S, and Arriagada R
(1995). Ductal carcinoma in situ: MRI imaging–histopathologic corre-
lation. Radiology 196, 415–19.
[22] Fischer U, Westerhof JP, Brinck U, Korabiowska M, Schauer A, and
Grabbe E (1996). The ductal carcinoma in situ in contrast-enhanced
dynamic MR mammography. RoFo 164, 290–94.
[23] Orel SG, Mendoca MH, Reynolds C, Schnall MD, Solin LJ, and Sulli-
van DC (1997). MR imaging of ductal carcinoma in situ. Radiology 202,
202, 413–20.
[24] Huang MM, Chen NG, Yuan BH, and Zhu Q (2003). 3D simultaneous
absorption and scattering coefficients reconstruction for the reflection
geometry. In Optical Tomography and Spectroscopy of Tissue V. B
Chance, RR Alfano, BJ Tromberg, M Tamura, EM Sevick-Muraca
(Eds). SPIE, Bellingham, WA. Vol. 4955, pp. 52–58.
388 Ultrasound-Guided Imaging of Breast Lesions Zhu et al.
Neoplasia . Vol. 5, No. 5, 2003
